Genmab — Februar 2025

[lahn1]

At de vil have børn med i godkendelsen fra start.

[troldmanden]

Hvilke peak sales estimater har i set på Mim8?

[Bulder]

Jeg har noteret 6,4 mia dkk i 2031. Kan ikke huske, hvor jeg har tallet fra.

[GUHO]

Citi har ligget højt på Mim8 på 1,9 mia. dollars mens konsensus skulle være 1,1. Samme artikel nævner 6,4 mia. dkk i 2031 som Bulder

[GUHO]

Page Not Found - NPinvestor x Netposten

NPinvestor x Netposten (npinvestor.dk)

[Bulder]

Helimbra solgte i 2023 for 4,7 mia $. https://finance.yahoo.com/news/hemlibra-emicizumab-sales-increase-8-055300995.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAFN6KMaKixReHe__AJhRzQORzfQmBY-WjuR584ocJwn_q8Ibw3pEEAXgR9CvT0hp04-RxR8AZs3_pCGnH80yXz1CXP-Ks2q3SLlATyV70hIzx0xetat5zg_xLXwOXN7u2UvuhZERCY2AE0p2sRV99xUzMnf02tkTrXJfvRdCS7jz

[E_L]

Hemab Therapeutics Presents Interim Data from Ongoing Phase 2 Study of HMB-001 as First Ever Prophylactic Treatment in Glanzmann Thrombasthenia and Preclinical Data from HMB-002 in Von Willebrand Disease at the 2025 EAHAD Annual Congress https://hemab.com/#post-hemab-therapeutics-presents-interim-data-from-ongoing-phase-2-study-of-hmb-001-as-first-ever-prophylactic-treatment-in-glanzmann-thrombasthenia-and-preclinical-data-from-hmb-002-in-von-willebrand-dise

[DaPhamius]

Hvad er forventningen til regnskabet på mandag?

[gdn55]

Mener først regnskabet kommer den 12.02, altså onsdag

[gdn55]

den

[DaPhamius]

Mente også onsdag. Forventer folk opdatering på JNJ og fremtidig pipeline eller rene tal som vi for det meste kender i forvejen?

[E_L]

we recently had a pipeline update, they will repeat that. they should give financial guidance for 2025

[ProinvestorNEWS]

Knock-Your-Socks-Off-News – February 2025 https://www.linkedin.com/pulse/knock-your-socks-off-news-february-2025-genmab-qlnee/

[Raun]

US noteringen er i gang med at finde nye bunde

[E_L]

Wolfgang Miesbach
@miesbach
Excellent presentation by Dr. Sivapalaratnam #EAHAD2025, prophylactic treatment results of a phase 1/2 study using bispecific antibody HMB-001 https://x.com/miesbach/status/1887942918117167354

[E_L]

Brian O Mahony
@Brianhemophilia
Sivapalaratnam #EAHAD2025 on HMB-001 trial for Glanzmanns. Encouraging data with significant reduction in treated bleeds. This is a very difficult condition with ABR up to 80. New treatment options urgently required. https://x.com/Brianhemophilia/status/1888457175405572604

[E_L]

man requiring red cell transfusions every ~10 days; could discontinue transfusions with HMB-001 after 43days

[E_L]

Nice graphic on how HMB-001 works in Glanzmanns. https://x.com/Brianhemophilia/status/1888457830392291557

[LP90]

der var salgspres på fra åbningen er der nogen der ved lidt som vi alm ikke har
viden om endnu ???

[w]

det er så vildt, det kursfald. regnede med 1500 ved et nej